Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Inconsistent dosing or skipping weekly injections ,ay reduce the medications effectiveness
Higher-tier drugs, such as non-preferred, branded prescription drugs or specialty drugs, typically have the highest copayment
Activation promotes neuronal survival, axon growth, synaptic plasticity
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Generic medications must demonstrate bioequivalence to the brand-name product, meaning they deliver the same amount of active ingredient into the bloodstream at the same rate
Subject to benefits and eligibility verification
US$ 20.10
US$ 22.92
US$ 27.66
US$ 22.84
US$ 22.40
